Yong Li

Yong Li

Auto-generated profile, based on publicly available information

Yong Li

School of Life Sciences, Anhui University, Hefei, Anhui Province, China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2018 in Oncogenesis
Verified
Journal Article
Open access
PDF file
HLHouli Liu
Houli Liu
MZMingsheng Zhang
Mingsheng Zhang
SXShanshan Xu
Shanshan Xu
JZJie Zhang
Jie Zhang
JZJin Zou
Jin Zou
YLYong Li
Yong Li
Homeobox (HOX) genes encode a family of transcription factors, which play crucial roles in numerous processes, and their dysregulation is involved in the carcinogenesis of many human cancers. In the present study, we investigated the roles of HOXC8 in non-small cell lung cancer (NSCLC). We showed that HOXC8 was upregulated in clinical NSCLC specimens compared to normal lung tissues, and the high expression of HOXC8 correlated with tumor node metastasis (TNM) stage, tumor status, lymph nodal status and poor relapse-free survival for lung cancer patients. Functionally, HOXC8 expression significantly promoted the proliferation, anchorage-independent growth and migration of NSCLC, and HOXC8 functioned as a transcription activator to induce the expression of TGFβ1, leading to an increase in the proliferation, anchorage-independent growth and migration of NSCLC. Furthermore, we demonstrated that HOXC8 expression was associated with chemoresistance and anti-apoptosis in NSCLC, suggesting that HOXC8 is a promising therapeutic target for chemosensitization of NSCLC to cisplatin. Altogether, our study defined a critical role of HOXC8 in promoting transcription of TGFβ1 and NSCLC tumorigenesis.

22 March 2014 in Oncotarget
Verified
Journal Article
Open access
PDF file
YLYong Li
Yong Li
FCFengmei Chao
Fengmei Chao
BHBei Huang
Bei Huang
DLDahai Liu
Dahai Liu
JKJaejik Kim
Jaejik Kim
SHShuang Huang
Shuang Huang
Cell-cell adhesion molecule cadherin-11(CDH11) is preferentially expressed in basal-like breast cancer cells and facilitates breast cancer cell migration by promoting small GTPase Rac activity. However, how the expression of CDH11 is regulated in breast cancer cells is not understood. Here, we show that CDH11 is transcriptionally controlled by homeobox C8 (HOXC8) in human breast cancer cells. HOXC8 serves as a CDH11-specific transcription factor and binds to the site of nucleotides -196 to -191 in the CDH11 promoter. Depletion of HOXC8 leads to the decrease in anchorage-independent cell growth, cell migration/invasion and spontaneous metastasis of breast cancer cells; however, suppressed tumorigenic events were fully rescued by ectopic CDH11 expression in HOXC8-knockdown cells. These results indicate that HOXC8 impacts breast tumorigenesis through CDH11. The analysis of publically available human breast tumor microarray gene expression database demonstrates a strong positive linear association between HOXC8 and CDH11 expression ( = 0.801, p < 0.001). Survival analysis (Kaplan-Meier method, log-rank test) show that both high HOXC8 and CDH11 expression correlate with poor recurrence-free survival rate of patients. Together, our study suggests that HOXC8 promotes breast tumorigenesis by maintaining high level of CDH11 expression in breast cancer cells.

1 July 2019 in Molecular Carcinogenesis
Verified
Journal Article
Closed access
PDF file
CGChen Gong
Chen Gong
JZJin Zou
Jin Zou
MZMingsheng Zhang
Mingsheng Zhang
JZJie Zhang
Jie Zhang
SXShanshan Xu
Shanshan Xu
YLYong Li
Yong Li

18 November 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
YZYang Zhang
Yang Zhang
CYChenchen Yang
Chenchen Yang
MZMingsheng zhang
Mingsheng zhang
HLHouli Liu
Houli Liu
CGChen Gong
Chen Gong
YLYong Li
Yong Li
Interleukin enhancer-binding factor 3 and HOXC8 co-activate cadherin 11 transcription to promote breast cancer cells proliferation and migration Interleukin enhancer-binding factor 3 and HOXC8 co-activate cadherin 11 transcription to promote breast cancer cells proliferation and migration

18 October 2018 in Clinical and Applied Thrombosis/Hemostasis
Verified
Journal Article
Open access
PDF file
XWXiangyu Wu
Xiangyu Wu
CGChen Gong
Chen Gong
JWJustin Weinstock
Justin Weinstock
JCJun Cheng
Jun Cheng
SHShengnan Hu
Shengnan Hu
XXXiping Xu
Xiping Xu
Our goal was to examine the associations of the 388A>G and 521T>C polymorphisms in the solute carrier organic anion transporter 1B1 (SLCO1B1) gene with hepatic function, baseline lipid levels, and the lipid-lowering efficiency of simvastatin. We recruited 542 patients with hyperlipidemia. The 388A>G and 521T>C polymorphisms were genotyped. Serum alanine aminotransferase (ALT) and aspartate transaminase (AST), Serum triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) levels were measured before and after an oral 20-mg dose of simvastatin. Individuals with the 388AA genotype had higher ALT and AST levels than those with the 388AG or 388GG genotypes (P = .037 and P = .002, respectively). Individuals with both the 388AA and the 521TT genotypes had the highest levels of ALT and AST (P = .001 and P = .001, respectively). Moreover, we divided all patients into normal and abnormal subgroups based on elevated ALT and AST values (≥ 40 U/L), participants in the abnormal subgroup had a higher frequency of the 388A/521T haplotype and a lower frequency of the 388G/521T haplotype compared to those in the normal subgroup. In addition, compared to 388G allele and 521C allele carriers, individuals with the 388G allele and 521TT genotype carriers had greater TC and LDL-C reduction in response to simvastatin after 4 weeks of treatment. Our conclusion suggests that the interaction between the SLCO1B1 388A>G and 521T>C polymorphisms could be an important genetic determinant of hepatic function and the therapeutic efficiency of simvastatin in Chinese patients with hyperlipidemia.

12 March 2024 in Biochemical Genetics
Verified
Journal Article
Closed access
PDF file
QCQian Chen
Qian Chen
MYMengqi Yang
Mengqi Yang
XDXinyue Duan
Xinyue Duan
JZJie Zhang
Jie Zhang
FSFan Shi
Fan Shi
YLYong Li
Yong Li